Market Research Reports and Industry Reports

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in US. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The population of Indonesia in 2014 was approximately 252 million, having grown at a CAGR of 1.7% from 2008. The country’s increasingly elderly population and a corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical market, which was worth $2.99 billion in 2008 and is projected to reach approximately $6.24 billion by 2014 at a Compound Annual Growth Rate (CAGR) of 12.4%. The overall market is estimated to reach $ 12.6 billion by 2020. New health insurance scheme Jaminan Kesehatan Nasional (JKN) - Universal Health Coverage (UHC) aims to provide health insurance to 250 million people by 2019. The Indonesia medical device market was valued at $793m in 2013 and is projected to grow at a CAGR of 4.9% to an estimated $872m billion in 2020.

These growth trends can be primarily attributed to:


Improved access to healthcare facilities
Increase in healthcare insurance coverage

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Indonesia, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Kalbe Farma, Tempo Scan Pacific, Kimia Farma, Darya Varia Laboratories and Indofarma and market overview of medical device market.

Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the healthcare market

Reasons To Buy


This report will enhance your decision-making capability by allowing you to:
Develop business strategies by understanding the trends shaping and driving Indonesia’s healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Indonesia’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
Identify, understand, and capitalize on the opportunities and challenges in Indonesia’s healthcare market

2 Introduction
 
 2.1 GlobalData Report Guidance
 
 3 Overview of Pharmaceutical and Medical Device Markets
 
 3.1 Pharmaceutical Market
 
 3.1.1 Market Overview
 
 3.1.2 Supply Channels
 
 3.1.3 Market Segments
 
 3.1.4 Major Drug Classes
 
 3.1.5 Major Players
 
 3.2 Medical Device Market
 
 3.2.1 Market Overview
 
 3.3 Market Drivers and Barriers
 
 3.3.1 Drivers
 
 3.3.2 Barriers
 
 4 Market Access
 
 4.1 Reimbursement and Payer Landscape
 
 4.1.1 Overview of Healthcare System
 
 4.1.2 Reimbursement Process
 
 4.1.3 Overview of Insurance Providers
 
 4.1.4 Patient Share of Healthcare Expenditure
 
 4.1.5 Healthcare Price Trends
 
 4.1.6 Pricing Policies
 
 4.2 Regulatory Landscape
 
 4.2.1 Overview of Regulatory Agencies
 
 4.2.2 Market Authorization Procedure for Pharmaceutical Products
 
 4.2.3 New Medical Device Approval Process
 
 4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
 
 4.2.5 Licensing Process for Pharmaceutical Exports and Imports
 
 4.2.6 Intellectual Property Rights
 
 4.2.7 Clinical Trial Regulations
 
 4.2.8 Pharmaceutical Advertising Regulations
 
 4.2.9 Pharmacy Regulations
 
 4.2.10 Labeling and Packaging Regulations
 
 5 Country Analysis
 
 5.1 Political Environment
 
 5.1.1 Political Structure
 
 5.1.2 Analysis of the Current Political Environment
 
 5.1.3 Healthcare Policy Initiatives
 
 5.2 Economic Landscape
 
 5.3 Economic Indicators
 
 5.3.1 Gross Domestic Product
 
 5.3.2 Gross National Income
 
 5.3.3 Inflation
 
 5.3.4 Currency Exchange Rate
 
 5.3.5 Foreign Direct Investment
 
 5.3.6 Foreign Exchange Reserves
 
 5.3.7 Trade Balance
 
 5.3.8 Government Structural Balance
 
 5.3.9 Government Gross Debt
 
 5.3.10 Major Industries
 
 5.4 Demographics
 
 5.4.1 Population
 
 5.4.2 Education and Literacy
 
 5.4.3 Employment
 
 5.4.4 Disease Burden
 
 5.5 Healthcare Infrastructure
 
 5.5.2 Healthcare Parameters
 
 5.5.3 Environmental Health
 
 5.5.4 Healthcare Personnel
 
 5.6 Healthcare Expenditure
 
 5.6.1 Overview of Healthcare Expenditure
 
 5.6.2 Major Components of Healthcare Expenditure
 
 5.6.3 Healthcare Expenditure Distribution
 
 5.7 Trade Associations
 
 5.7.1 International Pharmaceutical Manufacturers Group
 
 5.7.2 Indonesia Pharmaceutical Association
 
 5.7.3 Indonesia Medical Association
 
 5.8 Trade Fairs
 
 6 Opportunities and Challenges
 
 6.1 Opportunities
 
 6.2 Challenges
 
 7 Appendix
 
 7.1 Abbreviations
 
 7.2 Bibliography
 
 7.3 Research Methodology
 
 7.3.1 Coverage
 
 7.3.2 Secondary Research
 
 7.3.3 Forecasts
 
 7.3.4 Expert Panel
 
 7.4 Disclaimer


List Of Tables

Table 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2008–2015
 
 Table 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2015–2020
 
 Table 3: Pharmaceutical Market, Indonesia, Distribution Channel Price Margins (%), 2014
 
 Table 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014
 
 Table 5: Pharmaceutical Market, Indonesia, OTC, Revenue ($bn), 2008–2014
 
 Table 6: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2008–2014
 
 Table 7: Pharmaceutical Market, Indonesia, Major Therapeutic Areas (%), 2005
 
 Table 8: Pharmaceutical Market, Indonesia, Antibiotics Market Segments (%), 2005
 
 Table 9: Pharmaceutical Market, Indonesia, Respiratory Drug Market Segments (%), 2005
 
 Table 10: Pharmaceutical Market, Indonesia, Neuromuscular Drug Market Segments (%), 2005
 
 Table 11: Pharmaceutical Market, Indonesia, Vitamins and Minerals Market Segment (%), 2005
 
 Table 12: Pharmaceutical Market, Indonesia, Dermatological Drug Market Segments (%), 2005
 
 Table 13: Major Products, PT Kalbe Farma, Revenue, 2014
 
 Table 14: Major Products, PT Tempo Scan Pacific, 2014
 
 Table 15: Major Products, PT Darya-Varia Laboratoria, 2014
 
 Table 16: Major Products, PT Indofarma, 2014
 
 Table 17: Medical devices, Imports market size ($m), 2013
 
 Table 18: Overview of Insurance Providers, Indonesia, Health Insurance Coverage (%), 2011
 
 Table 19: Overview of Insurance Providers, Indonesia, Public Health Insurance Schemes Overview, 2010
 
 Table 20: Overview of Insurance Providers, Indonesia, Share of OOP Patient Healthcare Expenditure (%), 2008–2014
 
 Table 21: Overview of Insurance Providers, Indonesia, Healthcare Inflation (%), 2008–2014
 
 Table 22: Regulatory Landscape, Indonesia, New Drug Registration Categories, 2014
 
 Table 23: Regulatory Landscape, Indonesia, Patent Application Fees, 2014
 
 Table 24: Impact of Natural Calamities, Indonesia, 1996–2009
 
 Table 25: Economic Indicators, Indonesia, GDP per Capita ($), 2008–2015
 
 Table 26: Economic Indicators, Indonesia, GDP per Capita ($), Forecast, 2016–2020
 
 Table 27: Economic Indicators, Indonesia, GDP Annual Growth (%), 2008–2015
 
 Table 28: Economic Indicators, Indonesia, GDP Annual Growth (%), Forecast, 2016–2020
 
 Table 29: Economic Indicators, Indonesia, GNI per Capita ($), 2008–2014
 
 Table 30: Economic Indicators, Indonesia, CPI, 2008–2015
 
 Table 31: Economic Indicators, Indonesia, Consumer Price Index, Forecast, 2016–2020
 
 Table 32: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2008–2015
 
 Table 33: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2016–2020
 
 Table 34: Economic Indicators, Indonesia, Currency Exchange Rate (IDR/$), 2008–2014
 
 Table 35: Economic Indicators, Indonesia, FDI ($bn), 2008–2014
 
 Table 36: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2008–2014
 
 Table 37: Economic Indicators, Indonesia, Trade balance ($bn), 2008–2014
 
 Table 38: Economic Indicators, Indonesia, Imports ($bn), 2008–2014
 
 Table 39: Economic Indicators, Indonesia, Exports ($bn), 2008–2014
 
 Table 40: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2008–2014
 
 Table 41: Economic Indicators, Indonesia, Government Gross Debt ($bn), 2008–2014
 
 Table 42: Economic Indicators, Indonesia, Major industries by GDP share (%), 2014
 
 Table 43: Demographics, Indonesia, Population (million), 2008–2015
 
 Table 44: Demographics, Indonesia, Population (million), Forecast, 2016–2020
 
 Table 45: Demographics, Indonesia, Urban and Rural Population Share (%), 2008–2015
 
 Table 46: Demographics, Indonesia, Urban and Rural Population Share (%), 2016–2020
 
 Table 47: Demographics, Indonesia, Population Distribution by Age Group (%), 2008–2015
 
 Table 48: Demographics, Indonesia, Population Distribution by Age Group (%), Forecast, 2016–2020
 
 Table 49: Demographics, Indonesia, Births (Per 1,000 Population), 2008–2014
 
 Table 50: Demographics, Indonesia, Mortality (Per 1,000 Population), 2008–2014
 
 Table 51: Demographics, Indonesia, Causes of Mortality (‘000), 2012
 
 Table 52: Demographics, Indonesia, Children under Five, Mortality (Per 1,000 Live Births), 2008–2014
 
 Table 53: Demographics, Indonesia, Immunization Rate (%), 2008–2014
 
 Table 54: Demographics, Indonesia, Gender Ratio (M/F), 2008–2014
 
 Table 55: Demographics, Indonesia, Life Expectancy at Birth (Years), 2008–2015
 
 Table 56: Demographics, Indonesia, Life Expectancy at Birth (Years), 2016–2020
 
 Table 57: Demographics, Indonesia, Illiteracy by Age Group (%), 2008–2014
 
 Table 58: Demographics, Indonesia, School Enrollment by Age Group (%), 2014
 
 Table 59: Demographics, Indonesia, Unemployment (%), 2008–2014
 
 Table 60: Demographics, Indonesia, Causes of Hospitalization by Hospital Inpatients (Per 100,000 Population), 2010
 
 Table 61: Demographics, Indonesia, DALY (Per 100,000 Population), 2004
 
 Table 62: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2008–2014
 
 Table 63: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 Population), 2008–2014
 
 Table 64: Healthcare Infrastructure, Indonesia, Hospitals by Type of Care, 2014
 
 Table 65: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 100,000 Population), 2008–2014
 
 Table 66: Healthcare Infrastructure, Indonesia, Beds (Per 1,000 Population), 2008–2014
 
 Table 67: Healthcare Infrastructure, Indonesia, Physicians (Per 100,000 Population), 2008–2014
 
 Table 68: Environmental Health, Indonesia, CO2 Emissions (Million Metric Tons), 2008–2014
 
 Table 69: Environmental Health, Indonesia, PM10 Emissions (µg/m3), 2008–2014
 
 Table 70: Environmental Health, Indonesia, Access to Protected Drinking Water (%), 2013
 
 Table 71: Environmental Health, Indonesia, Share of Waste by Handling Method (%), 2008
 
 Table 72: Healthcare Personnel, Indonesia, Nurses (Per 100,000 Population), 2008–2014
 
 Table 73: Healthcare Personnel, Indonesia, Pharmacists (Per 100,000 Population), 2008–2014
 
 Table 74: Healthcare Personnel, Indonesia, Dentists (Per 100,000 Population), 2008–2014
 
 Table 75: Healthcare Expenditure, Indonesia, Healthcare Expenditure (% of GDP), 2008–2014
 
 Table 76: Healthcare Expenditure, Indonesia, Share of Major Components (%), 2008
 
 Table 77: Healthcare Expenditure, Indonesia, Public-Private Share of Healthcare Expenditure (%), 2008–2014
 
 Table 78: Trade Fairs, Indonesia, Major Healthcare Trade Fairs, 2013–2014


List Of Figures

Figure 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2008–2015
 
 Figure 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2015–2020
 
 Figure 3: Pharmaceutical Market, Indonesia, Distribution Chain, 2014
 
 Figure 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014
 
 Figure 5: Pharmaceutical Market, Indonesia, OTC, Revenue ($bn), 2008–2014
 
 Figure 6: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2008–2014
 
 Figure 7: Pharmaceutical Market, Indonesia, Major Therapeutic Areas (%), 2005
 
 Figure 8: Pharmaceutical Market, Indonesia, Antibiotics Market Segments (%), 2005
 
 Figure 9: Pharmaceutical Market, Indonesia, Respiratory Drug Market Segments (%), 2005
 
 Figure 10: Pharmaceutical Market, Indonesia, Neuromuscular Drug Market Segments (%), 2005
 
 Figure 11: Pharmaceutical Market, Indonesia, Vitamins and Minerals Market Segments (%), 2005
 
 Figure 12: Pharmaceutical Market, Indonesia, Dermatological Drug Market Segments (%), 2005
 
 Figure 13:Medical Device , Imports market size, 2013
 
 Figure 14: Healthcare Market, Indonesia, Drivers and Barriers, 2014
 
 Figure 15: Market Access, Indonesia, History of Health Insurance System, 1968–2014
 
 Figure 16: Market Access, Indonesia, Process for Addition to Hospital Drug Formulary, 2014
 
 Figure 17: Overview of Insurance Providers, Indonesia, Health Insurance Coverage (%), 2011
 
 Figure 18: Overview of Insurance Providers, Indonesia, Share of OOP Patient Healthcare Expenditure (%), 2008–2014
 
 Figure 19: Overview of Insurance Providers, Indonesia, Healthcare Inflation (%), 2008–2014
 
 Figure 20: Regulatory Landscape, Indonesia, Structure of the National Agency of Drug and Food Control, 2014
 
 Figure 21: Regulatory Landscape, Indonesia, New Drug Market Authorization Process, 2014
 
 Figure 22: Regulatory Landscape, Indonesia, Generic Drug Market Authorization Process, 2014
 
 Figure 23: Regulatory Landscape, Indonesia, Medical Device Approval Process, Indonesia, 2014
 
 Figure 24: Regulatory Landscape, Indonesia, Licensing Process for Manufacturing, 2014
 
 Figure 25: Regulatory Landscape, Indonesia, Structure of the Directorate General of Intellectual Property Office, 2014
 
 Figure 26: Regulatory Landscape, Indonesia, Patent Approval Process, 2014
 
 Figure 27: Regulatory Landscape, Indonesia, Clinical Trial Regulation Process, 2014
 
 Figure 28: Economic Indicators, Indonesia, GDP Per Capita ($), 2008–2015
 
 Figure 29: Economic Indicators, Indonesia, GDP per Capita ($), Forecast, 2016–2020
 
 Figure 30: Economic Indicators, Indonesia, GDP Annual Growth (%), 2008–2015
 
 Figure 31: Economic Indicators, Indonesia, GDP Annual Growth (%), Forecast, 2016–2020
 
 Figure 32: Economic Indicators, Indonesia, GNI per Capita ($), 2008–2014
 
 Figure 33: Economic Indicators, Indonesia, CPI, 2008–2015
 
 Figure 34: Economic Indicators, Indonesia, CPI, Forecast, 2016-2020
 
 Figure 35: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2008–2015
 
 Figure 36: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2016–2020
 
 Figure 37: Economic Indicators, Indonesia, Currency Exchange Rate (IDR/$), 2008–2014
 
 Figure 38: Economic Indicators, Indonesia, FDI ($bn), 2008–2014
 
 Figure 39: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2008–2014
 
 Figure 40: Economic Indicators, Indonesia, Trade Balance ($bn), 2008–2014
 
 Figure 41: Economic Indicators, Indonesia, Imports ($bn), 2008–2014
 
 Figure 42: Economic Indicators, Indonesia, Exports ($bn), 2008–2014
 
 Figure 43: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2008–2014
 
 Figure 44: Economic Indicators, Indonesia, Government Gross Debt ($bn), 2008–2014
 
 Figure 45: Economic Indicators, Indonesia, Major Industries by GDP Share (%), 2014
 
 Figure 46: Demographics, Indonesia, Population (million), 2008–2015
 
 Figure 47: Demographics, Indonesia, Population (million), Forecast, 2016–2020
 
 Figure 48: Demographics, Indonesia, Urban and Rural Population Share (%), 2008–2015
 
 Figure 49: Demographics, Indonesia, Urban and Rural Population Share (%), 2016–2020
 
 Figure 50: Demographics, Indonesia, Population Distribution by Age Group (%), 2008–2015
 
 Figure 51: Demographics, Indonesia, Population Distribution by Age Group (%), Forecast, 2016–2020
 
 Figure 52: Demographics, Indonesia, Births (Per 1,000 Population), 2008–2014
 
 Figure 53: Demographics, Indonesia, Mortality (Per 1,000 Population), 2008–2014
 
 Figure 54: Demographics, Indonesia, Causes of Mortality (‘000), 2012
 
 Figure 55: Demographics, Indonesia, Children under Five, Mortality (Per 1,000 Live Births), 2008–2014
 
 Figure 56: Demographics, Indonesia, Immunization Rate (%), 2008–2014
 
 Figure 57: Demographics, Indonesia, Gender Ratio (M/F), 2008–2014
 
 Figure 58: Demographics, Indonesia, Life Expectancy at Birth (Years), 2008–2015
 
 Figure 59: Demographics, Indonesia, Life Expectancy at Birth (Years), 2016–2020
 
 Figure 60: Demographics, Indonesia, Illiteracy by Age Group (%), 2008–2014
 
 Figure 61: Demographics, Indonesia, School Enrollment by Age Group (%), 2014
 
 Figure 62: Demographics, Indonesia, Unemployment (%), 2008–2014
 
 Figure 63: Demographics, Indonesia, Causes of Hospitalization by Hospital Inpatients (Per 100,000 Population), 2010
 
 Figure 64: Demographics, Indonesia, DALYs (Per 100,000 Population), 2004
 
 Figure 65: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2008–2014
 
 Figure 66: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 Population), 2008–2014
 
 Figure 67: Healthcare Infrastructure, Indonesia, Number of Hospitals by Type of Care, 2014
 
 Figure 68: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 100,000 Population), 2008–2014
 
 Figure 69: Healthcare Infrastructure, Indonesia, Beds (Per 1,000 Population), 2008–2014
 
 Figure 70: Healthcare Infrastructure, Indonesia, Physicians (Per 100,000 Population), 2008–2014
 
 Figure 71: Environmental Health, Indonesia, CO2 Emissions (Million Metric Tons), 2008–2014
 
 Figure 72: Environmental Health, Indonesia, PM10 Emissions (µg/m3), 2008–2014
 
 Figure 73: Environmental Health, Indonesia, Access to Protected Drinking Water, 2013
 
 Figure 74: Environmental Health, Indonesia, Share of Waste by Handling Method (%), 2008
 
 Figure 75: Healthcare Personnel, Indonesia, Nurses (Per 100,000 Population), 2008–2014
 
 Figure 76: Healthcare Personnel, Indonesia, Pharmacists (Per 100,000 Population), 2008–2014
 
 Figure 77: Healthcare Personnel, Indonesia, Dentists (Per 100,000 Population), 2008–2013
 
 Figure 78: Healthcare Expenditure, Indonesia, Healthcare Expenditure (% of GDP), 2008–2014
 
 Figure 79: Healthcare Expenditure, Indonesia, Share of Major Components (%), 2008
 
 Figure 80: Healthcare Expenditure, Indonesia, Public-Private Share of Healthcare Expenditure (%), 2008–2014
 
 Figure 81: Healthcare Market, Indonesia, Opportunities and Challenges, 2014


CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - ColombiaGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia. The report is an essential

USD 1995View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab EmiratesIn 2015, the UAE population was approximately at 9.6 million. The government of the UAE has been making continuous efforts to

USD 1995View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - MalaysiaGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia. The report is an essential

USD 1995View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - ColombiaGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia. The report is an essential

USD 1995View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab EmiratesIn 2015, the UAE population was approximately at 9.6 million. The government of the UAE has been making continuous efforts to

USD 1995View Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - MalaysiaGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia. The report is an essential

USD 1995View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF $ 1995    $ 1995
  • Site Licence $ 3990    $ 3990
  • Enterprise Wide Licence $ 5985    $ 5985
$ 1995

Reports Details

Published Date : Feb 2016
No. of Pages :179
Country :Indonesia
Category :Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment